In 2025, 23 million Americans purchased government-subsidized health insurance policies on government marketplaces. If they wish to renew those policies in 2026, their required out-of pocket payments will double. For many of them, this will make health insurance unaffordable.

For Americans as a group, their experience should serve as the canary in the coalmine. As a nation, our health care expenditures have been rising more rapidly than our income for several decades. This is not sustainable.

The German challenge

The United States is not the only high income country where the percentage of income devoted to heath care expenses has been increasing. This is to be expected, since populations are aging and new treatments have been making health care both more necessary and more expensive.

But, as the Commonwealth Fund reported, the increase in the percentage of national income devoted to medical expense has increased more rapidly in the U.S. than it has in other high income countries.

Advertise with us

For example, in 1980 the U.S. and Germany devoted approximately the same percentage of their national income to cover health care expenditures. But, by 2021 our percentage of income spent on health care was 39% higher than that spent by Germany — and Germany used a higher percentage of its income on health care than any other high income country except the United States.

Obviously, the other high income countries in the Commonwealth Fund study have done a better job at controlling the rate of growth of heath care expenditures than we have. They do at least three things that we don’t do, or don’t do as well:

First, their administrative costs consume a much lower share of their total health care costs than do administrative costs of insurance providers and medical providers in the United States.

Second, the cost of prescription drugs is much lower in other high income countries than in the United States.

Third, they have more medical doctors per capita, and a much higher ratio of general of doctors who are general practitioners than does the United States.

Advertise with us

Administration, drugs and education

The U.S has a large number of heath care insurers, each with different terms on which they will pay some or all of a policy holder’s health care expenses. It has been estimated that as much as 30% of all medical care expenses are actually used to pay for the administrative costs of both the insurance providers and the health care providers who receive payments from these multiple insurers.

By contrast, the non-U.S high income countries in the Commonwealth Fund study all have universal health insurance coverage by a single payer. One such country is Canada. A study of administrative costs of the health care systems in Canada and the U.S. found that Canada devoted half as much of its health care expenditures to cover administrative costs as did the United States.

There are enormous costs associated with finding and proving the efficacy of a new drug. But, once it is found and approved, the cost of manufacturing a dose of a drug is quite low, as is reflected in the difference in the price of a drug still under patent and its generic equivalent. The low cost of producing a drug under patent provides a lot of room for bargaining between the manufacturer and the entity paying for the drug.

In the U.S., the largest payer — Medicare — was actually prohibiting from negotiating prices with drug manufactures. That is not true of other countries who have universal, single payer, insurance systems.

In those countries the single payer has enormous bargaining leverage. In the U.S., private health insurers use the services of prescription benefits managers to negotiate with drug manufacturers for rebates. But, according to a recent Rand study, “After applying an adjustment for rebates paid by manufacturers, U.S. net prices for brand-name originator drugs were relatively lower but still over three times as high as prices in other countries.”

Advertise with us

Another reason for higher costs is how the systems create physicians. In the U.S. there are fewer physicians per thousand people than in other high income countries. With a lower supply relative to demand, it is not surprising that U.S. physicians are paid more than their European counterparts.

In addition, the ratio of general practitioners to specialists is much lower in the United States than in other high-income countries. So an individual seeking care in the U.S. is more likely to be getting the care of a high-priced specialist than of a lower-priced generalist in the United States than would be true in one of these other high income countries.

Both these factors make American health care more expensive than it is in other countries.

The German lesson

In Germany, tuition is free, and the total number of years required to complete studies to become a physician is less than in the U.S. The difference in income of a specialist and a general practitioner is much less than in the U.S.

It is not surprising that relatively more Germans enter medical school than do Americans or that a larger fraction of them choose to become general practitioners than do Americans.

Advertise with us

Others have shown that the rate of increase in the cost of health care can be better controlled. The question remains: Will we have the political will to learn from their experience?

Jack Ochs is professor of economics, emeritus, at the University of Pittsburgh. He lives in Point Breeze. Bert Rockman is professor of political science, emeritus, at Purdue University.